{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:52:51Z","timestamp":1777909971345,"version":"3.51.4"},"reference-count":32,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To determine the clinical effectiveness of combination therapy with intravitreal injection of triamcinolone acetonide (IVITA) and oral levodopa in eyes affected by nonarteritic anterior ischemic optic neuropathy (NAION).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Longitudinal study involving 45 eyes of 45 patients with NAION who were evaluated within 14 days of NAION onset. The treatment group received an IVITA 4\u2009mg\/0.1\u2009mL followed by 25\u2009mg carbidopa\/100\u2009mg levodopa (Sinemet 25\u2013100) 3 times daily for 12 weeks and the control group was untreated. Best-corrected visual acuity (BCVA) converted to logarithmic minimum angle of resolution (logMAR), visual field (VF) grades based on automated or Goldman perimetry, and mean retinal nerve fiber layer (RNFL) thickness measured on optical coherence tomography were assessed at the initial visit, 1, 3, and 6 months after NAION attack.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      At the first visit and 6 months after NAION onset, the mean logMAR BCVA in the treatment group was significantly better than the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.05). BCVA was not significantly different between onset and the 6-month visit for both the control and the treatment group; however, the change in BCVA after 6 months was significantly greater in the treatment group compared with the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.007). Concomitant systemic disease, the changes in VF grades, and RNFL thickness from initial to 6 months after NAION onset were not significantly different between 2 groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Combination therapy with IVITA and oral levodopa\/carbidopa appears to be effective in the treatment of recent-onset NAION.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jop.2021.0081","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T10:04:32Z","timestamp":1642673072000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Combination Therapy with Intravitreal Triamcinolone Acetonide and Oral Levodopa for the Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy: A Pilot Study"],"prefix":"10.1177","volume":"38","author":[{"given":"Hsiu-Mei","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung City, Taiwan (R.O.C.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsi-Kung","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung City, Taiwan (R.O.C.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Yu","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung City, Taiwan (R.O.C.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Chang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung City, Taiwan (R.O.C.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda Yi-Chieh","family":"Poon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung City, Taiwan (R.O.C.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-013-2399-z"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-020-01448-8"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.08.006"},{"key":"e_1_3_3_5_2","first-page":"625","article-title":"Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful","volume":"273","author":"Group IONDTR.","year":"1995","unstructured":"Group IONDTR. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA. 273:625\u2013632, 1995.","journal-title":"The Ischemic Optic Neuropathy Decompression Trial Research Group"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0805-8"},{"key":"e_1_3_3_7_2","first-page":"125","article-title":"Visual disturbances in systemic disorders","volume":"89","author":"Foulds W.S.","year":"1970","unstructured":"Foulds W.S. Visual disturbances in systemic disorders. Optic neuropathy and systemic disease. Trans. Ophthalmol. Soc. U. K. 89:125\u2013146, 1970.","journal-title":"Optic neuropathy and systemic disease"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-14-62"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-013-2499-9"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.041"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)70536-7"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6989(94)90248-8"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(90)90113-O"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1995.sp020543"},{"key":"e_1_3_3_15_2","first-page":"685","article-title":"Protective action of dopamine against glutamate neurotoxicity in the retina","volume":"35","author":"Kashii S.","year":"1994","unstructured":"Kashii S., , Takahashi M., , Mandai M., , Shimizu H., , Honda Y., , Sasa M., , Ujihara H., , Tamura Y., , Yokota T., , and Akaike A. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest. Ophthalmol. Vis. Sci. 35:685\u2013695, 1994.","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060236"},{"key":"e_1_3_3_17_2","first-page":"23","article-title":"Comparison of immediate-release and controlled release carbidopa\/levodopa in Parkinson's disease","volume":"37","author":"Block G.","year":"1997","unstructured":"Block G., , Liss C., , Reines S., , Irr J., , and Nibbelink D. Comparison of immediate-release and controlled release carbidopa\/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Eur. Neurol. 37:23\u201327, 1997.","journal-title":"A multicenter 5-year study. The CR First Study Group"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756285617737728"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-015-3191-z"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701562"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.05.027"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2016.08.003"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-006-0332-4"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0938.2008.00287.x"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0b013e31814a5a9a"},{"key":"e_1_3_3_26_2","first-page":"2069","article-title":"A new therapy of cerebral resuscitation","volume":"86","author":"Liu W.L.","year":"2006","unstructured":"Liu W.L., , and Shi N. A new therapy of cerebral resuscitation. Natl. Med. J. China. 86:2069\u20132071, 2006.","journal-title":"Natl. Med. J. China"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2007.11.010"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.11.026"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00133-5"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00462.x"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.12.044"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.02.002"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2010.1362"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jop.2021.0081","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2021.0081","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2021.0081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:44:45Z","timestamp":1777646685000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jop.2021.0081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3,1]]}},"alternative-id":["10.1089\/jop.2021.0081"],"URL":"https:\/\/doi.org\/10.1089\/jop.2021.0081","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}